Anxiety disorders are the most common mental health conditions in the United States, affecting roughly 40 million adults, and they co-occur with substance use disorder at strikingly high rates — about 30-40% of people with an anxiety disorder also develop a substance use disorder, most often involving alcohol or benzodiazepines, per the NIDA comorbidity research. The pairing is driven by a cruel biological irony: the substances people use to quiet anxiety in the short term make it worse in the long term.
This guide walks through why anxiety and addiction pair so often, the self-medication trap that worsens both, why the substances people reach for backfire, and the integrated treatment that addresses both at once. Updated April 2026. Medically reviewed by the RehabPulse editorial team. This is informational only — clinical decisions belong to a licensed clinician.
The 60-second answer
| Element | What to know |
|---|---|
| Co-occurrence | ~30-40% of people with anxiety disorders also have SUD |
| Most common substances | Alcohol and benzodiazepines (both GABA-acting depressants) |
| The trap | Substances quiet anxiety short-term, worsen it long-term via rebound |
| Two clinical pictures | Primary anxiety driving use; substance-induced anxiety that improves with sobriety |
| First-line therapy | CBT, exposure therapy, acceptance-based approaches |
| First-line medication | SSRIs/SNRIs for anxiety (not benzodiazepines for SUD patients) |
| Benzodiazepine caution | Generally avoided for anxiety in SUD patients — high dependence risk |
| Integrated outcomes | Substantially better than treating one condition at a time |
The single most important practical fact: the substances most people use to manage anxiety — alcohol and benzodiazepines — produce a rebound that worsens anxiety between uses, creating a cycle where the anxiety drives the use and the use deepens the anxiety. Most people don't know that the same GABA-enhancing mechanism that makes alcohol and benzos feel calming in the moment causes the brain to compensate by becoming more anxiety-prone over time. Breaking the cycle requires treating the anxiety directly with approaches that do not carry this rebound, while addressing the substance use.
Why anxiety and addiction pair so often
The high co-occurrence rate reflects a specific biological and behavioral logic, summarized from the NIDA and SAMHSA research:
- Self-medication. Anxiety is intensely uncomfortable — racing thoughts, physical tension, dread, social fear. Alcohol and benzodiazepines genuinely quiet it in the short term by enhancing GABA, the brain's inhibitory neurotransmitter. For someone with untreated anxiety, the relief is real, which is exactly what makes the pattern so easy to fall into.
- The rebound trap. Here is the cruel part. Chronic use of GABA-enhancing substances causes the brain to compensate by down-regulating its own GABA system and up-regulating excitatory glutamate. Between uses, the rebound is toward more anxiety than baseline. The substance that quieted the anxiety at 9 p.m. produces heightened anxiety at 6 a.m. — and the person reaches for it again. The anxiety worsens across weeks and months even as the dose stays constant.
- Shared vulnerability. Both anxiety disorders and substance use disorders share underlying risk factors — genetics, trauma, chronic stress, and dysregulation of the same brain stress systems. A person predisposed to one is often predisposed to the other.
- Withdrawal anxiety. Substance withdrawal itself produces anxiety, which can be mistaken for (or compound) an underlying anxiety disorder, deepening the cycle.
Picture this: a 35-year-old with social anxiety who started drinking to get through work events, found it genuinely helped, and five years later drinks daily — and notices that her anxiety is now far worse than when she started, with morning panic she never used to have. The alcohol did quiet her anxiety each evening. It also rewired her GABA-glutamate balance so that her baseline anxiety climbed steadily. Treating only the drinking leaves the social anxiety that drives it; treating only the anxiety leaves the dependence and the rebound cycle. The integrated approach treats both.
For the parallel pattern with trauma, our PTSD and alcohol use disorder guide covers the closely related co-occurrence. For depression, our depression and alcohol use disorder guide covers the third major pairing. Our dual diagnosis treatment guide covers the integrated model across all of them.
Why the substances people reach for backfire
The specific tragedy of anxiety-driven substance use is that the most common self-medication choices are the ones that worsen anxiety most over time.
- Alcohol. Enhances GABA and suppresses glutamate — calming in the moment. The rebound (especially overnight and in withdrawal) produces heightened anxiety, panic, and the "hangxiety" that heavy drinkers know well. Over months, baseline anxiety climbs. Our how long does alcohol withdrawal last guide covers the anxiety-heavy withdrawal.
- Benzodiazepines (Xanax, Ativan, Klonopin). The cruelest irony — these are prescribed for anxiety, work powerfully in the short term, and produce profound rebound anxiety and dependence with regular use. For someone with a substance use disorder, benzodiazepines are generally the wrong choice for anxiety because of the high dependence risk. Our benzodiazepine withdrawal timeline guide and Xanax addiction guide cover the dependence trap.
- Cannabis. Many people use cannabis for anxiety, and it helps some in the short term — but high-potency cannabis can produce anxiety and panic acutely, and heavy use is associated with worsening baseline anxiety.
Most people don't know that benzodiazepines, the medication class most associated with anxiety treatment, are generally avoided for anxiety in people with substance use disorder precisely because the dependence and rebound risk is so high. The first-line medications for anxiety in this population are SSRIs and SNRIs, which do not carry the same dependence or rebound profile.
Integrated treatment that works
The evidence-based approach treats anxiety and substance use disorder together, not sequentially.
For the therapy side:
- Cognitive-behavioral therapy (CBT). First-line for both anxiety and substance use disorder. Targets the thoughts and behaviors that maintain anxiety and the triggers that maintain use. Strong evidence for both conditions, especially when delivered by a clinician trained in both.
- Exposure therapy. For specific anxiety disorders (social anxiety, panic, phobias), gradual structured exposure to feared situations builds tolerance and reduces avoidance — the avoidance that substances often enable.
- Acceptance and commitment therapy (ACT) and mindfulness-based approaches. Strong evidence for anxiety; teach a different relationship to anxious thoughts and feelings that does not require escaping them with substances.
For the medication side:
- SSRIs (sertraline, escitalopram) and SNRIs (venlafaxine, duloxetine). First-line for anxiety in people with substance use disorder. They take 4-6 weeks for full effect, do not produce dependence, and do not carry the rebound problem of benzodiazepines. Our medication-assisted treatment guide covers how these combine with SUD medications.
- Buspirone. A non-addictive anti-anxiety medication, useful for generalized anxiety, with no dependence risk — a reasonable option for SUD patients.
- Naltrexone / acamprosate for the alcohol use disorder side, which combine safely with anxiety medications.
- Benzodiazepines: generally avoided. For SUD patients, the dependence and rebound risk usually outweighs the short-term benefit. Exceptions exist (short-term, closely monitored) but are the minority.
The combination of CBT plus an SSRI plus the appropriate substance use disorder treatment is the modal evidence-based package for moderate anxiety-AUD in 2026.
How to access integrated care
The realistic paths for someone with co-occurring anxiety and substance use disorder:
- Start with primary care or psychiatry. Most primary care physicians can prescribe SSRIs and refer to SUD treatment; psychiatrists can manage both. The key is finding a provider who treats both rather than one who treats the anxiety while ignoring the substance use or vice versa.
- Integrated dual diagnosis programs. Most metro areas have outpatient or residential programs designed for co-occurring mood/anxiety and substance use disorder. The SAMHSA findtreatment.gov directory filters for co-occurring disorder treatment.
- SAMHSA national helpline. 1-800-662-HELP (4357) — free, confidential, 24/7 — routes to integrated providers.
- Telehealth therapy + medication management. CBT and SSRI management are both available via telehealth, an increasingly common combination in 2026.
Three questions to ask any program: Is the anxiety treated directly (not just "it'll get better with sobriety")? Are benzodiazepines avoided in favor of SSRIs for the anxiety? Is there a psychiatrist coordinating with the addiction clinicians?
For the broader picture, our relapse prevention strategies guide covers managing anxiety-driven cravings. Other resources on RehabPulse:
Frequently asked questions
Why does anxiety lead to addiction? Anxiety is intensely uncomfortable, and alcohol, benzodiazepines, and cannabis genuinely quiet it in the short term by enhancing GABA, the brain's inhibitory neurotransmitter. For someone with untreated anxiety, the relief is real — which makes the self-medication pattern easy to fall into. The problem is the rebound: chronic use causes the brain to compensate, producing heightened anxiety between uses, deepening the cycle.
Do alcohol and benzos make anxiety worse? Yes, over time. Both enhance GABA and calm anxiety acutely, but chronic use causes the brain to down-regulate its own GABA system and up-regulate excitatory glutamate. The rebound, especially overnight and in withdrawal, produces heightened anxiety — worse than baseline. This is why people self-medicating anxiety with alcohol or benzos often find their anxiety steadily worsening even as the dose stays constant.
Can I take Xanax for anxiety if I'm in recovery? Generally not recommended. For people with substance use disorder, benzodiazepines like Xanax carry high dependence and rebound risk, and they are usually avoided in favor of SSRIs, SNRIs, or buspirone, which treat anxiety without the dependence problem. Exceptions exist (short-term, closely monitored use) but are the minority. Discuss anxiety medication options with a clinician who knows your substance use history.
What medication treats anxiety without addiction risk? SSRIs (sertraline, escitalopram), SNRIs (venlafaxine, duloxetine), and buspirone all treat anxiety without dependence risk and are first-line for anxiety in people with substance use disorder. They take 4-6 weeks for full effect but do not produce the rebound or dependence of benzodiazepines. Combined with CBT, they are the evidence-based approach for anxiety in recovery.
Does insurance cover treatment for anxiety and addiction together? Yes. Under the Mental Health Parity and Addiction Equity Act, both anxiety treatment and addiction treatment are covered at parity with other medical care. Most ACA, employer, Medicaid, Medicare, and VA plans cover psychiatric medication, CBT and other therapy, and integrated dual diagnosis programs. Verify benefits with the behavioral health number on your insurance card.
Sources and references
- National Institute on Drug Abuse (NIDA). Research Topics: Comorbidity. nida.nih.gov/research-topics/comorbidity
- Substance Abuse and Mental Health Services Administration (SAMHSA). Treatment Improvement Protocol (TIP) 42 — Co-Occurring Disorders. store.samhsa.gov
- National Institute of Mental Health (NIMH). Anxiety Disorders. nimh.nih.gov/health/topics/anxiety-disorders
- National Institute on Alcohol Abuse and Alcoholism (NIAAA). Alcohol and anxiety. niaaa.nih.gov
- SAMHSA. National Helpline — 1-800-662-HELP (4357), free and confidential 24/7. samhsa.gov/find-help/national-helpline
- SAMHSA. FindTreatment.gov treatment locator. findtreatment.gov
- NIDA. Principles of Drug Addiction Treatment: A Research-Based Guide. nida.nih.gov
